151 related articles for article (PubMed ID: 21366040)
1. Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors.
Mohammed HA; Ba LA; Burkholz T; Schumann E; Diesel B; Zapp J; Kiemer AK; Ries C; Hartmann RW; Hosny M; Jacob C
Nat Prod Commun; 2011 Jan; 6(1):31-4. PubMed ID: 21366040
[TBL] [Abstract][Full Text] [Related]
2. Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors.
Yahiaoui S; Pouget C; Buxeraud J; Chulia AJ; Fagnère C
Eur J Med Chem; 2011 Jun; 46(6):2541-5. PubMed ID: 21497425
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230
[TBL] [Abstract][Full Text] [Related]
4. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.
Sanderson JT; Hordijk J; Denison MS; Springsteel MF; Nantz MH; van den Berg M
Toxicol Sci; 2004 Nov; 82(1):70-9. PubMed ID: 15319488
[TBL] [Abstract][Full Text] [Related]
5. Combining computational and biochemical studies for a rationale on the anti-aromatase activity of natural polyphenols.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
ChemMedChem; 2007 Dec; 2(12):1750-62. PubMed ID: 17910019
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of (+/-)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer.
Maiti A; Cuendet M; Croy VL; Endringer DC; Pezzuto JM; Cushman M
J Med Chem; 2007 Jun; 50(12):2799-806. PubMed ID: 17511439
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and inhibition of PGE2 production of 6,8-disubstituted chrysin derivatives.
Park H; Dao TT; Kim HP
Eur J Med Chem; 2005 Sep; 40(9):943-8. PubMed ID: 15963606
[TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts--a comparative study.
van Meeuwen JA; Nijmeijer S; Mutarapat T; Ruchirawat S; de Jong PC; Piersma AH; van den Berg M
Toxicol Appl Pharmacol; 2008 May; 228(3):269-76. PubMed ID: 18201740
[TBL] [Abstract][Full Text] [Related]
9. Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme.
Gobbi S; Cavalli A; Rampa A; Belluti F; Piazzi L; Paluszcak A; Hartmann RW; Recanatini M; Bisi A
J Med Chem; 2006 Jul; 49(15):4777-80. PubMed ID: 16854084
[TBL] [Abstract][Full Text] [Related]
10. 4- and 6-(p-Sulphamoylphenyl)androstenediones: Studies of aromatase inhibitor-based oestrone sulphatase inhibition.
Watari Y; Yamaguchi S; Takahashi M; Nagaoka M; Numazawa M
Steroids; 2010 Dec; 75(12):891-6. PubMed ID: 20546769
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors: structural features and biochemical characterization.
Hong Y; Chen S
Ann N Y Acad Sci; 2006 Nov; 1089():237-51. PubMed ID: 17261771
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.
Kim YW; Hackett JC; Brueggemeier RW
J Med Chem; 2004 Jul; 47(16):4032-40. PubMed ID: 15267241
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents.
Jindal DP; Bedi V; Jit B; Karkra N; Guleria S; Bansal R; Palusczak A; Hartmann RW
Farmaco; 2005 Apr; 60(4):283-90. PubMed ID: 15848202
[TBL] [Abstract][Full Text] [Related]
14. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
Eur J Med Chem; 2009 Oct; 44(10):4121-7. PubMed ID: 19500885
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors.
Pouget C; Yahiaoui S; Fagnere C; Habrioux G; Chulia AJ
Bioorg Chem; 2004 Dec; 32(6):494-503. PubMed ID: 15530990
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
Li HQ; Shi L; Li QS; Liu PG; Luo Y; Zhao J; Zhu HL
Bioorg Med Chem; 2009 Sep; 17(17):6264-9. PubMed ID: 19664929
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibition by bioavailable methylated flavones.
Ta N; Walle T
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):127-9. PubMed ID: 17624765
[TBL] [Abstract][Full Text] [Related]
18. 6beta,19-Bridged androstenedione analogs as aromatase inhibitors.
Komatsu S; Yaguchi A; Yamashita K; Nagaoka M; Numazawa M
Steroids; 2009 Nov; 74(12):884-9. PubMed ID: 19524602
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
Bubert C; Woo LW; Sutcliffe OB; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2008 Nov; 3(11):1708-30. PubMed ID: 18816537
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents.
Suresh Babu K; Hari Babu T; Srinivas PV; Hara Kishore K; Murthy US; Rao JM
Bioorg Med Chem Lett; 2006 Jan; 16(1):221-4. PubMed ID: 16213726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
